T-Cell and NK-Cell Neoplasm — Trials

T-Cell and NK-Cell Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,103 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 201–250 of 321 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07339527	EZH2 Inhibitor Zeprumetostat in Combination Therapy for Patients With Relapsed or Refractory Mature T-cell and NK-cell Lymphomas	not yet recruiting	Phase 1 / Phase 2	60	Sun Yat-sen UniversityOTHER	0	Jan 14, 2026	clinicaltrials
NCT03278782	Study of Pembrolizumab (MK-3475) in Combination With Romidepsin	active not recruiting	Phase 1 / Phase 2	39	M.D. Anderson Cancer CenterOTHER	1	Jan 9, 2026	clinicaltrials